Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Foster

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Gut|June 17, 2010
Patients with m2 antibodies: what diagnosis and follow-up are they given?E A L Byrne, R Katbamna, C Scott, et al.
Gut|March 1, 1995
Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alphaJ C Booth, G R Foster, U Kumar, et al.
Epidemiology and Infection|April 18, 2018
Implementing routine blood-borne virus testing for HCV, HBV and HIV at a London Emergency Department - uncovering the iceberg?S Parry, N Bundle, S Ullah, et al.
Lancet (London, England)|November 23, 1996
Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral infectionH C Thomas, G R Foster, M Sumiya, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1994
Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycinT M Block, X Lu, F M Platt, et al.
Clinical Chemistry|November 1, 1989
Plasma glutathione S-transferase and F protein are more sensitive than alanine aminotransferase as markers of paracetamol (acetaminophen)-induced liver damageG J Beckett, G R Foster, A J Hussey, et al.
Alimentary Pharmacology & Therapeutics|August 30, 2008
Community-based treatment for chronic hepatitis C in drug users: high rates of compliance with therapy despite ongoing drug useM Wilkinson, V Crawford, A Tippet, et al.
Clinical Radiology|March 8, 2003
MR-guided laser thermal ablation of primary and secondary liver tumoursE A Dick, R Joarder, M de Jode, et al.
Journal of Viral Hepatitis|May 8, 2013
Analysis of genotype 2 and 3 hepatitis C virus variants in patients treated with telaprevir demonstrates a consistent resistance profile across genotypesS De Meyer, A Ghys, G R Foster, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 1, 1996
Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potencyG R Foster, O Rodrigues, F Ghouze, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Gut|June 17, 2010
Patients with m2 antibodies: what diagnosis and follow-up are they given?E A L Byrne, R Katbamna, C Scott, et al.
Gut|March 1, 1995
Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alphaJ C Booth, G R Foster, U Kumar, et al.
Epidemiology and Infection|April 18, 2018
Implementing routine blood-borne virus testing for HCV, HBV and HIV at a London Emergency Department - uncovering the iceberg?S Parry, N Bundle, S Ullah, et al.
Lancet (London, England)|November 23, 1996
Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral infectionH C Thomas, G R Foster, M Sumiya, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1994
Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycinT M Block, X Lu, F M Platt, et al.
Clinical Chemistry|November 1, 1989
Plasma glutathione S-transferase and F protein are more sensitive than alanine aminotransferase as markers of paracetamol (acetaminophen)-induced liver damageG J Beckett, G R Foster, A J Hussey, et al.
Alimentary Pharmacology & Therapeutics|August 30, 2008
Community-based treatment for chronic hepatitis C in drug users: high rates of compliance with therapy despite ongoing drug useM Wilkinson, V Crawford, A Tippet, et al.
Clinical Radiology|March 8, 2003
MR-guided laser thermal ablation of primary and secondary liver tumoursE A Dick, R Joarder, M de Jode, et al.
Journal of Viral Hepatitis|May 8, 2013
Analysis of genotype 2 and 3 hepatitis C virus variants in patients treated with telaprevir demonstrates a consistent resistance profile across genotypesS De Meyer, A Ghys, G R Foster, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 1, 1996
Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potencyG R Foster, O Rodrigues, F Ghouze, et al.
Pageof 9